Numaferm, a peptide production platform spun out of Heinrich Heine University Düsseldorf, raised a seven-digit euro (€1 = $1.1m) seed round today from investors including public-private partnership High Tech Gründerfonds (HTGF).
The European Investment Fund, an EU-owned agency tasked with providing capital to SMEs, also took part in the round alongside angel investors Detlev Riesner and Jürgen Schumacher.
Founded in 2017, Numaferm is developing a fermentative process that enables plannable, high-yield production of peptides, a fundamental component of cells. Current…
